Remove Cardiovascular Disease Remove Diabetes Remove General Cardiology
article thumbnail

Higher Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation Noted After Spinal Cord Injury

All About Cardiovascular System and Disorders

There are several factors which increase the risk of cardiovascular disease in survivors of spinal cord injury. They have a greater prevalence of obesity, dyslipidemia, metabolic syndrome and diabetes mellitus. Cardiovascular disease in spinal cord injury: an overview of prevalence, risk, evaluation, and management.

article thumbnail

Global Trends in Cardiovascular Diseases: Insights from the 2023 Almanac

Cardiology Update

The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. Original article: Mensah GA et al.

article thumbnail

CLEAR Trial of Bempedoic Acid

All About Cardiovascular System and Disorders

CLEAR trial was a double blind, randomized, placebo controlled trial of patients who were unable or unwilling to take statins due to unacceptable adverse effects and had or were at high risk for cardiovascular disease. There was no increase in new onset diabetes mellitus or worsening of diabetes mellitus. There was 29.2

article thumbnail

Highlights of ACC 2024

Cardiology Update

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). STEP-HFpEF DM 5 ( NCT04916470 ) explored the effects of semaglutide in obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes. Presented at: ACC 2024.

Angina 52
article thumbnail

Sugar-sweetened beverages linked with about three hundred and forty thousand deaths from type 2 diabetes and cardiovascular disease globally – Study

All About Cardiovascular System and Disorders

A study published in Nature Medicine evaluated the burden of type 2 diabetes and cardiovascular disease attributable to sugar sweetened beverages in 184 countries [1]. million cases of new type 2 diabetes was attributable to sugar sweetened beverages worldwide, which was 9.8% In 2020, 2.2 of incident cases. In 2020, 2.2